anti-AKR7L antibody product blog
Tags: Antibody; Polyclonal Antibody; AKR7L; anti-AKR7L antibody;
The AKR7L akr7l (Catalog #MBS856607) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The AKR7L Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s AKR7L can be used in a range of immunoassay formats including, but not limited to, Peptide ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC).Peptide ELISA: 1:10,000-1:40,000
WB: 1:500-1:1,000
IHC: 1:100-1:500. Researchers should empirically determine the suitability of the AKR7L akr7l for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The AKR7L akr7l product has the following accession number(s) (GI #54612242) (NCBI Accession #AAH35351.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the AKR7L Antibody with the following immunoassay(s):
Testing Data
Testing Data
Rabbit polyclonal AKR7L (1) antibody was raised against a peptide from intermediate residues of human AKR7L protein.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AKR7L are readily searchable from our website. Different antibodies against the same target such as AKR7L may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.